
Determining E&L risk from single-use components can be used to build the level of extractable profiling and PERLs.
Determining E&L risk from single-use components can be used to build the level of extractable profiling and PERLs.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Published: March 15th 2024 | Updated: